Slc16a14 Rat (-)-demecolcine decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Demecolcine results in decreased expression of SLC16A14 mRNA CTD PMID:23649840 Slc16a14 Rat 17beta-estradiol decreases expression ISO Slc16a14 (Mus musculus) 6480464 Estradiol results in decreased expression of SLC16A14 mRNA CTD PMID:19484750 Slc16a14 Rat 17beta-estradiol increases expression ISO SLC16A14 (Homo sapiens) 6480464 Estradiol results in increased expression of SLC16A14 mRNA CTD PMID:31614463 Slc16a14 Rat 17beta-estradiol multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC16A14 mRNA CTD PMID:30165855 Slc16a14 Rat 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of SLC16A14 mRNA CTD PMID:26496021 Slc16a14 Rat 2,2',5,5'-tetrachlorobiphenyl increases expression ISO SLC16A14 (Homo sapiens) 6480464 2 more ... CTD PMID:36804509 Slc16a14 Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Slc16a14 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Slc16a14 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc16a14 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC16A14 mRNA CTD PMID:21570461 Slc16a14 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC16A14 mRNA CTD PMID:33387578 Slc16a14 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC16A14 mRNA CTD PMID:27913140 Slc16a14 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC16A14 mRNA CTD PMID:28522335 Slc16a14 Rat 4,4'-sulfonyldiphenol decreases expression ISO Slc16a14 (Mus musculus) 6480464 bisphenol S results in decreased expression of SLC16A14 mRNA CTD PMID:33297965 Slc16a14 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC16A14 mRNA CTD PMID:24780913 Slc16a14 Rat aflatoxin B1 increases methylation ISO SLC16A14 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC16A14 intron CTD PMID:30157460 Slc16a14 Rat aldehydo-D-glucose multiple interactions ISO Slc16a14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA CTD PMID:37567420 Slc16a14 Rat all-trans-retinoic acid decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SLC16A14 mRNA CTD PMID:33167477 Slc16a14 Rat arsane affects methylation ISO SLC16A14 (Homo sapiens) 6480464 Arsenic affects the methylation of SLC16A14 gene CTD PMID:25304211 Slc16a14 Rat arsane multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC16A14 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC16A14 mRNA CTD PMID:39836092 Slc16a14 Rat arsenic atom affects methylation ISO SLC16A14 (Homo sapiens) 6480464 Arsenic affects the methylation of SLC16A14 gene CTD PMID:25304211 Slc16a14 Rat arsenic atom multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC16A14 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC16A14 mRNA CTD PMID:39836092 Slc16a14 Rat belinostat multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A14 mRNA CTD PMID:27188386 Slc16a14 Rat belinostat decreases expression ISO SLC16A14 (Homo sapiens) 6480464 belinostat results in decreased expression of SLC16A14 mRNA CTD PMID:26272509 Slc16a14 Rat benzo[a]pyrene increases expression ISO Slc16a14 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC16A14 mRNA CTD PMID:23735875 Slc16a14 Rat benzo[a]pyrene diol epoxide I decreases expression ISO SLC16A14 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Slc16a14 Rat bis(2-ethylhexyl) phthalate decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of SLC16A14 mRNA CTD PMID:31163220 Slc16a14 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of SLC16A14 mRNA CTD PMID:26496021 Slc16a14 Rat bisphenol A increases expression ISO SLC16A14 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC16A14 mRNA CTD PMID:29275510 Slc16a14 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC16A14 mRNA CTD PMID:30816183 and PMID:38750585 Slc16a14 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC16A14 mRNA CTD PMID:25181051 Slc16a14 Rat butan-1-ol multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC16A14 mRNA CTD PMID:29432896 Slc16a14 Rat calcitriol decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Calcitriol results in decreased expression of SLC16A14 mRNA CTD PMID:21592394 Slc16a14 Rat calcitriol multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SLC16A14 mRNA CTD PMID:21592394 Slc16a14 Rat cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of SLC16A14 mRNA CTD PMID:18500788 Slc16a14 Rat CGP 52608 multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC16A14 gene] CTD PMID:28238834 Slc16a14 Rat chlorpyrifos increases expression ISO Slc16a14 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SLC16A14 mRNA CTD PMID:34289071 Slc16a14 Rat copper atom multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC16A14 mRNA CTD PMID:20971185 Slc16a14 Rat copper atom decreases expression EXP 6480464 Copper results in decreased expression of SLC16A14 mRNA CTD PMID:30556269 Slc16a14 Rat copper(0) multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC16A14 mRNA CTD PMID:20971185 Slc16a14 Rat copper(0) decreases expression EXP 6480464 Copper results in decreased expression of SLC16A14 mRNA CTD PMID:30556269 Slc16a14 Rat copper(II) chloride decreases expression ISO SLC16A14 (Homo sapiens) 6480464 cupric chloride results in decreased expression of SLC16A14 mRNA CTD PMID:38568856 Slc16a14 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC16A14 mRNA CTD PMID:26577399 Slc16a14 Rat cyclosporin A decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC16A14 mRNA CTD PMID:27989131 Slc16a14 Rat D-glucose multiple interactions ISO Slc16a14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA CTD PMID:37567420 Slc16a14 Rat DDE increases expression ISO SLC16A14 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of SLC16A14 mRNA CTD PMID:38568856 Slc16a14 Rat dorsomorphin multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Slc16a14 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC16A14 mRNA CTD PMID:29391264 Slc16a14 Rat entinostat decreases expression ISO SLC16A14 (Homo sapiens) 6480464 entinostat results in decreased expression of SLC16A14 mRNA CTD PMID:26272509 Slc16a14 Rat entinostat multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A14 mRNA CTD PMID:27188386 Slc16a14 Rat ethanol multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC16A14 mRNA CTD PMID:29432896 Slc16a14 Rat ethanol increases expression ISO SLC16A14 (Homo sapiens) 6480464 Ethanol results in increased expression of SLC16A14 mRNA CTD PMID:31059573 and PMID:37149095 Slc16a14 Rat ethyl methanesulfonate decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC16A14 mRNA CTD PMID:23649840 Slc16a14 Rat fenfluramine decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Fenfluramine results in decreased expression of SLC16A14 mRNA CTD PMID:22140631 Slc16a14 Rat formaldehyde decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SLC16A14 mRNA CTD PMID:23649840 Slc16a14 Rat fructose multiple interactions ISO Slc16a14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA CTD PMID:37567420 Slc16a14 Rat glucose multiple interactions ISO Slc16a14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA CTD PMID:37567420 Slc16a14 Rat GW 4064 decreases expression ISO Slc16a14 (Mus musculus) 6480464 GW 4064 results in decreased expression of SLC16A14 mRNA CTD PMID:26655953 Slc16a14 Rat leflunomide increases expression ISO SLC16A14 (Homo sapiens) 6480464 leflunomide results in increased expression of SLC16A14 mRNA CTD PMID:28988120 Slc16a14 Rat lipopolysaccharide multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC16A14 mRNA CTD PMID:35811015 Slc16a14 Rat lipopolysaccharide decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of SLC16A14 mRNA CTD PMID:35811015 Slc16a14 Rat manganese atom multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC16A14 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC16A14 mRNA CTD PMID:39836092 Slc16a14 Rat manganese(0) multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC16A14 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC16A14 mRNA CTD PMID:39836092 Slc16a14 Rat manganese(II) chloride multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC16A14 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC16A14 mRNA CTD PMID:39836092 Slc16a14 Rat methyl methanesulfonate decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC16A14 mRNA CTD PMID:23649840 Slc16a14 Rat methylmercury chloride increases expression ISO SLC16A14 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of SLC16A14 mRNA CTD PMID:28001369 Slc16a14 Rat N-methyl-4-phenylpyridinium increases expression ISO SLC16A14 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC16A14 mRNA CTD PMID:24810058 Slc16a14 Rat N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC16A14 mRNA CTD PMID:28801915 Slc16a14 Rat niclosamide increases expression ISO SLC16A14 (Homo sapiens) 6480464 Niclosamide results in increased expression of SLC16A14 mRNA CTD PMID:36318118 Slc16a14 Rat ochratoxin A decreases methylation EXP 6480464 ochratoxin A results in decreased methylation of SLC16A14 gene CTD PMID:26431795 Slc16a14 Rat orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of SLC16A14 mRNA CTD PMID:23665939 Slc16a14 Rat ozone decreases expression ISO Slc16a14 (Mus musculus) 6480464 Ozone results in decreased expression of SLC16A14 mRNA CTD PMID:33026818 Slc16a14 Rat ozone multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC16A14 mRNA CTD PMID:35430440 Slc16a14 Rat panobinostat multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A14 mRNA CTD PMID:27188386 Slc16a14 Rat panobinostat decreases expression ISO SLC16A14 (Homo sapiens) 6480464 panobinostat results in decreased expression of SLC16A14 mRNA CTD PMID:26272509 Slc16a14 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC16A14 mRNA CTD PMID:30723492 Slc16a14 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC16A14 mRNA CTD PMID:33387578 Slc16a14 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLC16A14 mRNA CTD PMID:32680482 Slc16a14 Rat potassium chromate decreases expression ISO SLC16A14 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of SLC16A14 mRNA CTD PMID:22714537 Slc16a14 Rat rotenone increases expression ISO SLC16A14 (Homo sapiens) 6480464 Rotenone results in increased expression of SLC16A14 mRNA CTD PMID:29955902 Slc16a14 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC16A14 mRNA CTD PMID:35811015 Slc16a14 Rat SB 431542 multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Slc16a14 Rat sodium arsenite decreases expression ISO SLC16A14 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC16A14 mRNA CTD PMID:38568856 Slc16a14 Rat sodium arsenite multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC16A14 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC16A14 mRNA CTD PMID:39836092 Slc16a14 Rat sodium arsenite increases expression ISO SLC16A14 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC16A14 mRNA CTD PMID:34032870 Slc16a14 Rat sulforaphane increases expression ISO SLC16A14 (Homo sapiens) 6480464 sulforaphane results in increased expression of SLC16A14 mRNA CTD PMID:31838189 Slc16a14 Rat sunitinib decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SLC16A14 mRNA CTD PMID:31533062 Slc16a14 Rat temozolomide decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Temozolomide results in decreased expression of SLC16A14 mRNA CTD PMID:31758290 Slc16a14 Rat testosterone multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SLC16A14 mRNA CTD PMID:21592394 Slc16a14 Rat testosterone decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Testosterone results in decreased expression of SLC16A14 mRNA CTD PMID:21592394 Slc16a14 Rat thimerosal increases expression ISO SLC16A14 (Homo sapiens) 6480464 Thimerosal results in increased expression of SLC16A14 mRNA CTD PMID:27188386 Slc16a14 Rat thiram decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Thiram results in decreased expression of SLC16A14 mRNA CTD PMID:38568856 Slc16a14 Rat titanium dioxide decreases expression ISO Slc16a14 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SLC16A14 mRNA CTD PMID:29264374 Slc16a14 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC16A14 mRNA CTD PMID:33387578 Slc16a14 Rat trichostatin A increases expression ISO SLC16A14 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLC16A14 mRNA CTD PMID:24935251 Slc16a14 Rat trichostatin A multiple interactions ISO SLC16A14 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A14 mRNA CTD PMID:27188386 Slc16a14 Rat trichostatin A decreases expression ISO SLC16A14 (Homo sapiens) 6480464 trichostatin A results in decreased expression of SLC16A14 mRNA CTD PMID:24935251 and PMID:26272509 Slc16a14 Rat valproic acid affects expression ISO SLC16A14 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC16A14 mRNA CTD PMID:25979313 Slc16a14 Rat valproic acid decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SLC16A14 mRNA CTD PMID:23179753 more ... Slc16a14 Rat valproic acid increases expression ISO SLC16A14 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC16A14 mRNA CTD PMID:24935251 Slc16a14 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC16A14 mRNA CTD PMID:23869203 Slc16a14 Rat vincristine decreases expression ISO SLC16A14 (Homo sapiens) 6480464 Vincristine results in decreased expression of SLC16A14 mRNA CTD PMID:23649840 Slc16a14 Rat zoledronic acid decreases expression ISO SLC16A14 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of SLC16A14 mRNA CTD PMID:24714768